| Literature DB >> 28250312 |
Sang-Ik Oh1,2, Albert Byungyun Jeon1, Byeong-Yeal Jung1, Jae-Won Byun1, Marcelo Gottschalk3, Aeran Kim1, Jong Wan Kim1, Ha-Young Kim1.
Abstract
Streptococcus suis is an important pig pathogen with potential for human transmission. The serotype distributions and phenotypic characteristics vary over time and among regions; however, little is known about the characteristics of S. suis isolates in Korea. In this study, 240 S. suis isolates collected from pigs in Korea in 2009-2010 were serotyped by coagglutination tests, subsequently screened for three virulence-associated genes (mrp, epf and sly) and tested for antimicrobial susceptibility. As for 80 isolates, the serotypes of which were relevant to human infections, clonal complexes (CCs) were further identified by PCR. Serotype 3 was the most prevalent (15.8%), followed by serotype 2 (15.0%), with geographical variation for each serotype. Overall, 55.4% of the isolates carried mrp, whereas only 3.8% carried epf. CC25 was the most prevalent (41.3%) and was related to serotypes 2 and 9. The isolates showed higher susceptibility to ampicillin (93.4%) and ceftiofur (90.8%) than to the other antimicrobial agents tested. The highest resistance rate was observed to tetracycline (98.0%), followed by erythromycin (88.8%). In addition, the resistance to certain antimicrobials was significantly associated, in part, with virulence-associated genes or serotypes. Therefore, continuous characterization of S. suis is essential for the benefit of veterinary and human medicine.Entities:
Keywords: Streptococcus suis; antimicrobial susceptibility; clonal complex; serotype; virulence-associated gene
Mesh:
Substances:
Year: 2017 PMID: 28250312 PMCID: PMC5402202 DOI: 10.1292/jvms.16-0514
Source DB: PubMed Journal: J Vet Med Sci ISSN: 0916-7250 Impact factor: 1.267
Distribution of virulence-associated genes in Streptococcus suis isolates from pigs in Korea
| Serotype | No. of isolates (%) | No. of isolates (slaughtered pigs/diseased pigs)a) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Slaughtered | Diseased | Total | ||||||||
| 1 | 0 (0) | 1 (1.0) | 1 (0.4) | 0 | 1 (0/1) | 0 | 0 | 0 | 0 | |
| 2 | 21 (14.8) | 15 (15.3) | 36 (15.0) | 0 | 30 (21/9) | 0 | 0 | 3 (0/3) | 3 (0/3) | |
| 1/2 | 12 (8.5) | 4 (4.1) | 16 (6.7) | 0 | 13 (12/1) | 0 | 0 | 2 (0/2) | 1 (0/1) | |
| 3 | 21 (14.8) | 17 (17.3) | 38 (15.8) | 1 (1/0) | 28 (14/14) | 0 | 9 (6/3) | 0 | 0 | |
| 4 | 3 (2.1) | 8 (8.2) | 11 (4.6) | 0 | 2 (0/2) | 3 (3/0) | 6 (0/6) | 0 | 0 | |
| 5 | 2 (1.4) | 1 (1.0) | 3 (1.3) | 0 | 0 | 1 (1/0) | 2 (1/1) | 0 | 0 | |
| 6 | 3 (2.1) | 0 (0) | 3 (1.3) | 0 | 0 | 3 (3/0) | 0 | 0 | 0 | |
| 7 | 5 (3.5) | 4 (4.1) | 9 (3.8) | 1 (1/0) | 1 (0/1) | 0 | 7 (4/3) | 0 | 0 | |
| 8 | 2 (1.4) | 5 (5.1) | 7 (2.9) | 0 | 0 | 6 (2/4) | 1 (0/1) | 0 | 0 | |
| 9 | 8 (5.6) | 6 (6.1) | 14 (5.8) | 1 (1/0) | 0 | 13 (7/6) | 0 | 0 | 0 | |
| 14 | 3 (2.1) | 0 (0) | 3 (1.3) | 0 | 3 (3/0) | 0 | 0 | 0 | 0 | |
| 16 | 6 (4.2) | 0 (0) | 6 (2.5) | 5 (5/0) | 1 (1/0) | 0 | 0 | 0 | 0 | |
| 17 | 0 (0) | 1 (1.0) | 1 (0.4) | 0 | 0 | 1 (0/1) | 0 | 0 | 0 | |
| 18 | 1 (0.7) | 0 (0) | 1 (0.4) | 0 | 0 | 1 (1/0) | 0 | 0 | 0 | |
| 19 | 1 (0.7) | 1 (1.0) | 2 (0.8) | 0 | 0 | 1 (1/0) | 1 (0/1) | 0 | 0 | |
| 20 | 3 (2.1) | 0 (0) | 3 (1.3) | 3 (3/0) | 0 | 0 | 0 | 0 | 0 | |
| 21 | 1 (0.7) | 5 (5.1) | 6 (2.5) | 3 (1/2) | 0 | 3 (0/3) | 0 | 0 | 0 | |
| 22 | 1 (0.7) | 2 (2.0) | 3 (1.3) | 1 (1/0) | 2 (0/2) | 0 | 0 | 0 | 0 | |
| 23 | 6 (4.2) | 0 (0) | 6 (2.5) | 0 | 0 | 0 | 6 (6/0) | 0 | 0 | |
| 24 | 1 (0.7) | 0 (0) | 1 (0.4) | 1 (1/0) | 0 | 0 | 0 | 0 | 0 | |
| 25 | 1 (0.7) | 0 (0) | 1 (0.4) | 1 (1/0) | 0 | 0 | 0 | 0 | 0 | |
| 28 | 1 (0.7) | 1 (1.0) | 2 (0.8) | 2 (1/1) | 0 | 0 | 0 | 0 | 0 | |
| 29 | 2 (1.4) | 5 (5.1) | 7 (2.9) | 4 (2/2) | 0 | 3 (0/3) | 0 | 0 | 0 | |
| 33 | 2 (1.4) | 0 (0) | 2 (0.8) | 2 (2/0) | 0 | 0 | 0 | 0 | 0 | |
| aab) | 22 (15.5) | 11 (11.2) | 33 (13.8) | 21 (21/0) | 4 (0/4) | 8 (1/7) | 0 | 0 | 0 | |
| ntc) | 14 (9.9) | 11 (11.2) | 25 (10.4) | 13 (11/2) | 0 | 5 (1/4) | 7 (2/5) | 0 | 0 | |
| Total (%) | 142 | 98 | 240 | 59 (24.6) | 85 (35.4) | 48 (20.0) | 39 (16.3) | 5 (2.1) | 4 (1.7) | |
a) (Number of isolates from slaughtered pigs/Number of isolates from diseased pigs), b) aa, Auto-agglutinated, c) nt, Non-typable.
Regional distribution of serotypes in Streptococcus suis isolates from pigs in Korea
| Serotype | No. of isolates (%) | ||
|---|---|---|---|
| Northern | Central | Southern | |
| 1 | 0 | 1 (0.8) | 0 |
| 2a) | 14 (16.0) | 13 (10.3) | 9 (35.0) |
| 1/2a) | 3 (3.4) | 13 (10.3) | 0 |
| 3a) | 6 (6.8) | 27 (21.4) | 5 (19.0) |
| 4a) | 3 (3.4) | 7 (5.6) | 1 (3.8) |
| 5 | 1 (1.1) | 2 (1.6) | 0 |
| 6 | 2 (2.3) | 1 (0.8) | 0 |
| 7 | 5 (5.7) | 3 (2.4) | 1 (3.8) |
| 8 | 4 (4.5) | 3 (2.4) | 0 |
| 9 | 7 (8.0) | 6 (4.8) | 1 (3.8) |
| 14a) | 0 | 1 (0.8) | 2 (7.7) |
| 16 | 3 (3.4) | 3 (2.4) | 0 |
| 17 | 0 | 1 (0.8) | 0 |
| 18 | 1 (1.1) | 0 | 0 |
| 19 | 0 | 2 (1.6) | 0 |
| 20 | 1 (1.1) | 2 (1.6) | 0 |
| 21 | 1 (1.1) | 5 (4.0) | 0 |
| 22 | 2 (2.3) | 1 (0.8) | 0 |
| 23 | 4 (4.5) | 2 (1.6) | 0 |
| 24 | 0 | 1 (0.8) | 0 |
| 25 | 1 (1.1) | 0 | 0 |
| 28 | 1 (1.1) | 0 | 1 (3.8) |
| 29 | 1 (1.1) | 6 (4.8) | 0 |
| 33 | 1 (1.1) | 1 (0.8) | 0 |
| aab) | 16 (18.2) | 13 (10.3) | 4 (15.4) |
| ntc) | 11 (12.5) | 12 (9.5) | 2 (7.7) |
| Total | 88 | 126 | 26 |
a) Significantly different, P<0.05, b) aa, Auto-agglutinated, c) nt, Non-typable.
Distribution of serotype, clonal complex and virulence-associated profile of Streptococcus suis isolates
| Clonal complex | Serotype | No. of isolates | |||||
|---|---|---|---|---|---|---|---|
| CC1 (n=1) | 2 | 0 | 0 | 0 | 0 | 0 | 1 |
| CC25 (n=33) | 2 | 0 | 28 | 0 | 0 | 3 | 1 |
| 9 | 0 | 0 | 1 | 0 | 0 | 0 | |
| CC28 (n=6) | 2 | 0 | 2 | 0 | 0 | 0 | 1 |
| 14 | 0 | 3 | 0 | 0 | 0 | 0 | |
| CC221/234 (n=20) | 4 | 0 | 1 | 1 | 5 | 0 | 0 |
| 5 | 0 | 0 | 0 | 2 | 0 | 0 | |
| 9 | 1 | 0 | 7 | 0 | 0 | 0 | |
| 21 | 2 | 0 | 1 | 0 | 0 | 0 | |
| NDa) (n=20) | 7 | 2 | 10 | 1 | 0 | 0 | |
a) ND, not detected.
Cumulative percentage of Streptococcus suis (n=240) inhibited by eight antimicrobials, and antimicrobial resistance, MIC50, and MIC90 of Streptococcus suis isolates from slaughtered (n=142) and diseased pigs (n=98)
| Antimicrobials | Cumulative percentage of strains inhibited at
antimicrobial concentration
( | % resistance | MIC50b) | MIC90b) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ≤0.032 | 0.064 | 0.125 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | 128 | 256 | ≥512 | Slaughtered | Diseased | Slaughtered | Diseased | Slaughtered | Diseased | ||||
| Ampicillin | 77.1 | 85.4 | 89.6 | 93.4 | 95.5 | 98 | 98.8 | 99.2 | 99.6 | 100 | 1.4 | 9.2 | 0.032 | 0.032 | 0.25 | 1 | ||||||||
| Ceftiofur | 55 | 63.3 | 80.4 | 85.4 | 90.8 | 95.8 | 97 | 98.2 | 100 | 2.1 | 7.1 | 0.064 | 0.25 | 2 | 4 | |||||||||
| Chloramphenicol | 0.4 | 2.5 | 5.8 | 26.2 | 87.4 | 94.1 | 97.4 | 98.6 | 99.4 | 100 | 7.7 | 19.4 | 8 | 8 | 8 | 16 | ||||||||
| Enrofloxacin | 0.4 | 10 | 61.2 | 89.1 | 92 | 92.4 | 94.9 | 98.7 | 100 | 6.3 | 17.3 | 0.5 | 0.5 | 1 | 16 | |||||||||
| Erythromycin | 7.5 | 8.7 | 11.2 | 11.6 | 12.4 | 12.8 | 13.6 | 100 | 83.3 | 95.9 | 256 | 256 | 256 | 256 | ||||||||||
| Florfenicol | 0.4 | 1.2 | 31.6 | 69.5 | 87.4 | 93.6 | 96.1 | 97.3 | 100 | 26.8 | 35.7 | 4 | 4 | 8 | 16 | |||||||||
| Tetracycline | 0.8 | 1.2 | 2 | 3.2 | 3.6 | 14.8 | 45.2 | 92.7 | 98.9 | 99.3 | 100 | 97.9 | 98.0 | 64 | 64 | 64 | 64 | |||||||
| Tiamulin | 1.7 | 20.5 | 41.3 | 54.2 | 57.5 | 58.3 | 61.2 | 65 | 75.4 | 89.6 | 91.7 | 100 | - | - | 2 | 2 | 256 | 128 | ||||||
a) Susceptible and resistance breakpoints are indicated in vertical single (sensitive) and double (resistant) lines according to the guidelines of CLSI [5]. Human-derived breakpoints were applied for chloramphenicol and erythromycin, and no breakpoint was established for tiamulin [5], b) MIC50 and MIC90 are the concentrations at which the growth of 50% and 90% of the isolates is inhibited, respectively.
Distribution of antimicrobial resistance, virulence-associated genes and serotypes among Streptococcus suis isolates (n=240) from pigs in Korea
| Antimicrobials | No. of isolatesa) | No. of isolatesb) | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 1/2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 14 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 33 | aa | nt | |||||
| Ampicillin | 2 | 4 | 8c) | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | |
| Ceftiofur | 1 | 2 | 5 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 3 | |
| Chloramphenicol | 1 | 9c) | 16 | 0 | 4 | 0 | 2 | 1 | 1 | 0 | 1 | 2 | 2 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 2 | 0 | 1 | 7 | |
| Enrofloxacin | 3 | 8 | 13 | 0 | 2 | 1 | 2 | 1 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 6 | 4 | |
| Erythromycin | 9 | 120c) | 82 | 1 | 35c) | 7c) | 38c) | 10 | 3 | 1 | 9 | 6 | 14 | 3 | 6 | 1 | 1 | 2 | 3 | 6 | 3 | 3 | 1 | 0 | 2 | 7 | 2 | 25 | 22 | |
| Florfenicol | 3 | 38 | 28 | 0 | 7 | 2 | 14 | 5 | 2 | 1 | 2 | 0 | 4 | 2 | 2 | 0 | 0 | 0 | 2 | 2 | 1 | 0 | 0 | 0 | 1 | 2 | 1 | 10 | 11 | |
| Tetracycline | 9 | 132 | 87 | 1 | 36 | 16 | 38 | 10 | 3 | 3 | 8 | 7 | 14 | 3 | 6 | 1 | 1 | 2 | 3 | 6 | 3 | 4 | 1 | 1 | 2 | 7 | 2 | 31 | 25 | |
| Tiamulin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |
a) Number of resistance isolates with respect to expression of the virulence-associated gene, b) Number of resistance isolates with respect to serotypes of Streptococcus suis; aa, Auto-agglutinated; nt, Non-typable, c) Significantly different, P<0.05.